Comprehensive search of SNPs in patients with advanced renal cell carcinoma associated with efficacy and adverse events of molecular targeted therapies
Not Applicable
Recruiting
- Conditions
- renal cell carcinoma
- Registration Number
- JPRN-UMIN000020709
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. HIV infection, or B/C active hepatitis 2. Active infection (grade 3 or more defined by CTCAE version 3) 3. Inadequate case in physicians opinion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identify the SNPs in patients with advanced renal cell carcinoma associated with efficacy and adverse events of molecular targeted therapies
- Secondary Outcome Measures
Name Time Method 1. Identify the clinical factors in patients with advanced renal cell carcinoma associated with efficacy and adverse events of molecular targeted therapies 2. Identify the SNPs associated with oncogenesis of renal cell carcinoma